The behavioural and neurochemical profile of the putative dopamine D-3 receptor agonist, (+)-PD 128907, in the rat

被引:43
|
作者
Bristow, LJ
Cook, GP
Gay, JC
Kulagowski, JJ
Landon, L
Murray, F
Saywell, KL
Young, L
Hutson, PH
机构
[1] Merck Sharp and Dohme Res. Labs., Neuroscience Research Centre, Harlow CM20 2QR, Terlings Park, Eastwick Rd
关键词
dopamine D-3 receptor; catecholamine synthesis; locomotor activity; stereotyped behaviour; prepulse inhibition;
D O I
10.1016/0028-3908(96)00179-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The functional relevance of the dopamine D-3 receptor is still unresolved, largely because of the absence of selective D-3 receptor ligands. In the present study we have examined the in vivo profile of (+)-PD 128907, a potent and functionally selective D-3 receptor agonist. Low doses of (+)-PD 128907 reduced spontaneous locomotor activity in the rat (ED(50) = 13 +/- 3 mu g/kg, s.c.) a response which was comparable with the non-selective D-2/3 receptor agonist apomorphine (ED(50) = 13 +/- 1.6 mu g/kg, s.c.). In addition (+)-PD 128907 impaired prepulse inhibition of the acoustic startle response, with significant effects observed at doses of 30 mu g/kg when appropriate prepulse intensities were used. Higher doses reversed gamma-butyrolactone-induced catecholamine synthesis (ED(50) = 95 +/- 22 and 207 +/- 37 mu g/kg in accumbens and striatum respectively) and induced yawning (100-300 mu g/kg), penile grooming (30-1000 mu g/kg) and sniffing (greater than or equal to 300 mu g/kg) although doses 3- to 10-fold greater than apomorphine were required to produce maximal effects. In contrast to apomorphine, however, (+)-PD 128907 failed to induce intense stereotyped licking and biting in the rat. In view of the potency and selectivity of(+)-PD 128907 for the D-3 receptor, a role in the control of locomotor activity is suggested. In addition, the observation that (+)-PD 128907 disrupts prepulse inhibition, a phenomenon which is also impaired in schizophrenic subjects, may indicate the pathological importance of this receptor subtype. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:285 / 294
页数:10
相关论文
共 50 条
  • [31] A DOPAMINE D-3 RECEPTOR AGONIST, 7-OH-DPAT, CAUSES VOMITING IN THE DOG
    YOSHIDA, N
    YOSHIKAWA, T
    HOSOKI, K
    LIFE SCIENCES, 1995, 57 (21) : PL347 - PL350
  • [32] Effects of the putative dopamine D-3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline
    Lamas, X
    Negus, SS
    Nader, MA
    Mello, NK
    PSYCHOPHARMACOLOGY, 1996, 124 (04) : 306 - 314
  • [33] BEHAVIORAL-EFFECTS OF THE PUTATIVE D-3 DOPAMINE RECEPTOR AGONIST 7-OH-DPAT IN RELATION TO OTHER D-2-LIKE AGONISTS
    DALY, SA
    WADDINGTON, JL
    NEUROPHARMACOLOGY, 1993, 32 (05) : 509 - 510
  • [34] 7-OH-DPAT and PD 128907 Selectively Activate the D3 Dopamine Receptor in a Novel Environment
    Laurel M Pritchard
    Aaron D Logue
    Scott Hayes
    Jeffrey A Welge
    Ming Xu
    Jianhua Zhang
    S Paul Berger
    Neil M Richtand
    Neuropsychopharmacology, 2003, 28 : 100 - 107
  • [35] Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 oil dialysate dopamine levels
    Zapata, A
    Shippenberg, TS
    NEUROPHARMACOLOGY, 2005, 48 (01) : 43 - 50
  • [36] Dopamine D-3 receptors in rat juxtaglomerular cells
    Sanada, H
    Yao, L
    Jose, PA
    Carey, RM
    Felder, RA
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1997, 19 (1-2) : 93 - 105
  • [37] High affinity binding for pramipexole, a dopamine D-3 receptor ligand, in rat striatum
    Piercey, MF
    Walker, EL
    Feldpausch, DL
    CamachoOchoa, M
    NEUROSCIENCE LETTERS, 1996, 219 (02) : 138 - 140
  • [38] Codistribution of the dopamine D-3 receptor and glucocorticoid receptor mRNAs during striatal prenatal development in the rat
    Diaz, R
    Sokoloff, P
    Fuxe, K
    NEUROSCIENCE LETTERS, 1997, 227 (02) : 119 - 122
  • [39] Neurochemical characteristics of amisulpride, an atypical dopamine D-2/D-3 receptor antagonist with both presynaptic and limbic selectivity
    Schoemaker, H
    Claustre, Y
    Fage, D
    Rouquier, L
    Chergui, K
    Curet, O
    Oblin, A
    Gonon, F
    Carter, C
    Benavides, J
    Scatton, B
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (01): : 83 - 97
  • [40] The dopamine D3-preferring D2/D3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia
    Watson, David J. G.
    King, Madeleine V.
    Gyertyan, Istvan
    Kiss, Bela
    Adham, Nika
    Fone, Kevin C. F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (02) : 208 - 224